Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Nigel Crockett, Chief Business Officer of Bicycle Therapeutics PLC, sold 972 ordinary shares to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).
Summary
- On October 3, 2024, Nigel Crockett, the Chief Business Officer of Bicycle Therapeutics PLC, sold 972 ordinary shares of the company.
- The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
- The shares were sold at a weighted average price of $22.26, with individual transactions ranging from $21.91 to $22.56.
- Following the transaction, Crockett directly owns 45,822 ordinary shares of Bicycle Therapeutics PLC.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes). It doesn't convey any strong positive or negative sentiment about the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a routine practice among corporate executives. This transaction is not necessarily indicative of the executive's sentiment towards the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 10/03/2024 | Date of the share sale transaction. |
| 10/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.